Demographic characteristics |
|
|
|
Age |
79.5 ± 9.5 |
82.0 ± 8.1 |
<.0001 |
Female, N (%) |
2741 (44.1%) |
4412 (43.2%) |
0.28 |
Midwest |
1,351 (21.7%) |
2191 (21.5%) |
0.69 |
South |
2506 (40.3%) |
3904 (38.2%) |
0.01 |
West |
1,307 (21.0%) |
1,842 (18.0%) |
<.0001 |
Northeast |
1,051 (16.9%) |
2,266 (22.2%) |
<.0001 |
Encounter characteristics |
|
|
|
Inpatient implant |
3,309 (53.2%) |
5,790 (56.7%) |
<.0001 |
Days to implant |
2.5±5.3 |
1.9±3.6 |
<.0001 |
Weekend implant |
163 (2.6%) |
353 (3.5%) |
0.003 |
Admission through the ED |
745 (12.0%) |
1,105 (10.8%) |
0.02 |
Clinical Characteristics |
|
|
|
ESRD |
744 (12.0%) |
238 (2.3%) |
<.0001 |
Diabetes |
2,805 (45.1%) |
4,222 (41.3%) |
<.0001 |
Atrial fibrillation |
5,066 (81.5%) |
9,088 (89.0%) |
<.0001 |
Congestive heart failure |
3,282 (52.8%) |
5,391 (52.8%) |
0.98 |
Chronic Obstructive Pulmonary Disease |
1,931 (31.1%) |
2,975 (29.1%) |
0.01 |
Chronic steroid use |
246 (4.0%) |
327 (3.2%) |
0.01 |
Coronary Artery Disease |
3,489 (56.1%) |
5,447 (53.3%) |
0.001 |
Supraventricular tachycardia |
476 (7.7%) |
534 (5.2%) |
<.0001 |
Ventricular arrythmia |
979 (15.7%) |
1,403 (13.7%) |
0.0004 |
Hyperlipidemia |
4,770 (76.7%) |
7,578 (74.2%) |
0.0003 |
Left bundle branch block |
334 (5.4%) |
543 (5.3%) |
0.88 |
Peripheral vascular disease |
1,685 (27.1%) |
2,736 (26.8%) |
0.67 |
Prior coronary artery bypass graft |
929 (14.9%) |
1,460 (14.3%) |
0.26 |
Prior acute myocardial infarction |
1,242 (20.0%) |
1,680 (16.5%) |
<.0001 |
Prior percutaneous coronary intervention |
979 (15.7%) |
1,416 (13.9%) |
0.001 |
Renal dysfunction |
3,034 (48.8%) |
4,294 (42.1%) |
<.0001 |
Tricuspid valve disease |
1,795 (28.9%) |
2,945 (28.8%) |
0.97 |
Transcatheter Aortic Valve Replacement |
106 (1.7%) |
154 (1.5%) |
0.33 |
Concomitant atrial† ablation |
861 (13.8%) |
1,125 (11.0%) |
<.0001 |
Concomitant TAVR |
170 (2.7%) |
474 (4.6%) |
<.0001 |
Charlson Comorbidity Index |
5.1 ± 3.4 |
4.6 ± 3.0 |
<.0001 |
Follow-up time (days) |
675 ± 364 |
727 ± 366 |
<.0001 |